Delivery Order SPE2DB22D2211-SPE2DB25FSCNR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,213.80 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors, with an ultimate completion date of July 29, 2025. The contract, issued on July 28, 2025, employs firm fixed-price pricing and was awarded through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Emgality 120 mg/ml pen injectors, with a ceiling value of $1,554.86. This firm fixed-price delivery order is scheduled for completion by July 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating open competition. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,729.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $3,034.80 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors. This firm fixed-price, competitively awarded contract was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. No set-aside designation was applied to this award. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,074.80 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen/ml, a pharmaceutical product used in migraine treatment. This non-competitive, firm fixed-price delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,458.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injections on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside award was competitively procured and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplied the product...
- The Defense Logistics Agency awarded a delivery order valued at $1,729.00 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen, a migraine treatment medication. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,037.40 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pens on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen operates as a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $3,309.37 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen injectors. This firm fixed price, competitively awarded contract was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,729.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of July 23, 2025. This is a non-set-aside, competitively awarded contract for pharmaceutical supply, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCNRDelivery Order
The Defense Logistics Agency awarded a $1,729.00 delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract executed on August 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Emgality is a calcitonin gene-related peptide (CGRP) antagonist used for migraine prevention, representing the type of specialty pharmaceutical product that supports military and federal healthcare systems' medical supply needs. This delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of pharmaceutical products and medical supplies serving Defense Health Agency, the U.S. Coast Guard, and other government healthcare systems. The company's competitively awarded contracts demonstrate its capability to fulfill diverse federal medical supply requirements across multiple therapeutic domains, from specialty medications to vaccines and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/8/25 |